NovaBridge Biosciences (NBP) Assets Average (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Assets Average for 4 consecutive years, with $724.4 million as the latest value for Q4 2022.

  • Quarterly Assets Average fell 20.91% to $724.4 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $724.4 million through Dec 2022, down 20.91% year-over-year, with the annual reading at $734.8 million for FY2022, 20.55% down from the prior year.
  • Assets Average for Q4 2022 was $724.4 million at NovaBridge Biosciences, down from $915.9 million in the prior quarter.
  • The five-year high for Assets Average was $915.9 million in Q4 2021, with the low at $295.1 million in Q4 2019.
  • Average Assets Average over 4 years is $634.1 million, with a median of $662.8 million recorded in 2020.
  • The sharpest move saw Assets Average soared 103.72% in 2020, then dropped 20.91% in 2022.
  • Over 4 years, Assets Average stood at $295.1 million in 2019, then surged by 103.72% to $601.1 million in 2020, then skyrocketed by 52.36% to $915.9 million in 2021, then fell by 20.91% to $724.4 million in 2022.
  • According to Business Quant data, Assets Average over the past three periods came in at $724.4 million, $915.9 million, and $601.1 million for Q4 2022, Q4 2021, and Q4 2020 respectively.